Oro‐mammary inoculation pathway of monkeypox in a female patient

Mancha, Dora; Brazão, Cláudia; Filipe, Paulo

doi:10.1111/jdv.18672

Cited by 2 publications

(6 citation statements)

References 8 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Out of the 957 unique items, 928 were discarded, based on the title and/or abstract screening. Out of the twenty-nine studies screened for their full text, six studies were excluded with reason, while the remaining twenty-three studies [ 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 ] from various locations, including Argentina, Brazil, Colombia, Nigeria, Europe, Vietnam, and the USA, were retained and overviewed. More in detail, six cohort studies [ 28 , 29 , 30 , 31 , 32 , 33 ] were retrieved and synthesized, along with fourteen clinical case reports [ 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 ], two case series [ 48 , 49 ], and one case series review [ 50 ] ( Figure 1 ).…”

Section: Resultsmentioning

confidence: 99%

“…Mancha et al [ 39 ] reported the unusual case of a 30-year-old female (Fitzpatrick phototype III), highlighting not only this disease’s potential to affect a broader population but also, and especially, a rather rare, previously undocumented transmission route, namely oro-mammary sex with a partner who had symptoms suggestive of tonsillitis (which was later confirmed to be Mpox). This emphasizes the viability of the virus in saliva and the potential for transmission through intimate, non-genital contact.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to the Female Sex at Birth: A Comprehensive, Critical Global Perspective

Bragazzi,

Woldegerima,

et al. 2024

Viruses

View full text Add to dashboard Cite

The 2022–2023 Mpox multi-country outbreak, identified in over 110 WHO Member States, revealed a predominant impact on cisgender men, particularly those engaging in sex with men, while less frequently affecting women. This disparity prompted a focused investigation into the gender-specific characteristics of Mpox infections, particularly among women, to address a notable knowledge gap. This review systematically gathers and analyzes the scientific literature and case reports concerning Mpox infections in women, covering a broad geographical spectrum including regions such as Argentina, Brazil, Colombia, Nigeria, Europe, Vietnam, and the United States. The analysis delves into various aspects of Mpox in women, including clinical features, epidemiology, psychological impacts, preparedness strategies, and case studies, with particular attention to pregnant women and those with underlying health conditions. Empirical data from multiple studies underscore the unique epidemiological and clinical patterns of Mpox in women. In the United States, a small percentage of Mpox cases were reported among cisgender women, with a notable portion involving non-Hispanic Black or African American, non-Hispanic White, and Hispanic or Latino ethnicities. The primary transmission route was identified as sexual or close intimate contact, with the virus predominantly manifesting on the legs, arms, and genital areas. Further, a study in Spain highlighted significant disparities in diagnosis delays, transmission modes, and clinical manifestations between genders, indicating a different risk profile and disease progression in women. Additionally, a case from Vietnam, linked to a new Mpox sub-lineage in women, emphasized the role of women in the transmission dynamics and the importance of genomic monitoring. This review emphasizes the necessity for inclusive surveillance and research to fully understand Mpox dynamics across diverse population groups, including women. Highlighting gender and sexual orientation in public health responses is crucial for an effective approach to managing the spread and impact of this disease. The findings advocate for a gender-diverse assessment in health services and further research to explore the nuances of Mpox transmission, behavior, and progression among different groups, thereby enhancing the global response to Mpox and similar public health challenges.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to the Female Sex at Birth: A Comprehensive, Critical Global Perspective

Bragazzi,

Woldegerima,

et al. 2024

Viruses

View full text Add to dashboard Cite

show abstract

“…Overall, these clinical case reports and case series highlight the variability in transmission routes and treatment approaches for Mpox, as well as the broad age range of affected individuals (Table 3). [32] reported the unusual case of a 30-year-old female (Fitzpatrick phototype III), highlighting not only the disease's potential to affect a broader population but also, and especially, a rather rare, previously undocumented transmission route, namely oro-mammary sex with a partner who had symptoms suggestive of tonsillitis (which was later confirmed to be Mpox). This emphasizes the viability of the virus in saliva and the potential for transmission through intimate, non-genital contact.…”

Section: Case Reports and Case Seriesmentioning

confidence: 97%

“…Out of 957 unique items, 928 were discarded, based on title and/or abstract screening. Out of twenty-nine studies screened in full-text, thirteen studies were excluded with reason while the remaining sixteen studies [26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] from various locations including Buenos Aires, Brazil, Northern California, Colombia, Nigeria, Europe, Vietnam, Spain, Switzerland, and the USA were retained and overviewed. More in detail, six cohort studies [26][27][28][29][30][31] were retrieved and synthesized, along with seven clinical case reports [32][33][34][35][36][37][38], two case series [39,40], and one case series review [41] (Figure 1).…”

Section: Literature Searchmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to Female Sex at Birth: A Comprehensive, Critical Global Perspective

Bragazzi,

Woldegerima,

et al. 2024

Preprint

View full text Add to dashboard Cite

The 2022-2023 Mpox multi-country outbreak, identified in over 110 WHO Member States, revealed a predominant impact on cisgender men, particularly those engaging in sex with men, while less frequently affecting women. This disparity prompted a focused investigation into the gender-specific characteristics of Mpox infections, particularly among women, to address a notable knowledge gap. This review systematically gathers and analyzes scientific literature and case reports concerning Mpox infections in women, covering a broad geographical spectrum including regions such as Buenos Aires, Brazil, Northern California, Colombia, Nigeria, Europe, Vietnam, Spain, Switzerland, and the United States. The analysis delves into various aspects of Mpox in women, including clinical features, epidemiology, psychological impacts, preparedness strategies, and case studies, with particular attention to pregnant women and those with underlying health conditions. Empirical data from multiple studies underscore the unique epidemiological and clinical patterns of Mpox in women. In the United States, a small percentage of Mpox cases were reported among cisgender women, with a notable portion involving non-Hispanic Black or African American, non-Hispanic White, and Hispanic or Latino ethnicities. The primary transmission route was identified as sexual or close intimate contact, with the virus predominantly manifesting on the legs, arms, and genital areas. Further, a study in Spain highlighted significant disparities in diagnosis delays, transmission modes, and clinical manifestations between genders, indicating a different risk profile and disease progression in women. Additionally, a case from Vietnam linked to a new Mpox sublineage in women emphasizes the role of women in the transmission dynamics and the importance of genomic monitoring. This review emphasizes the necessity for inclusive surveillance and research to fully understand Mpox dynamics across diverse population groups, including women. Highlighting gender and sexual orientation in public health responses is crucial for an effective approach to managing the spread and impact of the disease. The findings advocate for a gender-diverse assessment in health services and further research to explore the nuances of Mpox transmission, behavior, and progression among different groups, thereby enhancing the global response to Mpox and similar public health challenges.

show abstract

Oro‐mammary inoculation pathway of monkeypox in a female patient

Cited by 2 publications

References 8 publications

Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to the Female Sex at Birth: A Comprehensive, Critical Global Perspective

Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to the Female Sex at Birth: A Comprehensive, Critical Global Perspective

Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to Female Sex at Birth: A Comprehensive, Critical Global Perspective

Contact Info

Product

Resources

About